APA

Froelich M. F., Heinemann V., Sommer W. H., Holch J. W., Schoeppe F., Hesse N., Baumann A. B., Kunz W. G., Reiser M. F., Ricke J., D'Anastasi M., Stintzing S., Modest D. P., Kazmierczak P. M. & Hofmann F. O. (20190501). CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. : European radiology.

Chicago

Froelich Matthias F, Heinemann Volker, Sommer Wieland H, Holch Julian W, Schoeppe Franziska, Hesse Nina, Baumann Alena B, Kunz Wolfgang G, Reiser Maximilian F, Ricke Jens, D'Anastasi Melvin, Stintzing Sebastian, Modest Dominik P, Kazmierczak Philipp M and Hofmann Felix O. 20190501. CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. : European radiology.

Harvard

Froelich M. F., Heinemann V., Sommer W. H., Holch J. W., Schoeppe F., Hesse N., Baumann A. B., Kunz W. G., Reiser M. F., Ricke J., D'Anastasi M., Stintzing S., Modest D. P., Kazmierczak P. M. and Hofmann F. O. (20190501). CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. : European radiology.

MLA

Froelich Matthias F, Heinemann Volker, Sommer Wieland H, Holch Julian W, Schoeppe Franziska, Hesse Nina, Baumann Alena B, Kunz Wolfgang G, Reiser Maximilian F, Ricke Jens, D'Anastasi Melvin, Stintzing Sebastian, Modest Dominik P, Kazmierczak Philipp M and Hofmann Felix O. CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial. : European radiology. 20190501.